The anticancer potential of chemical constituents of Moringa oleifera targeting CDK-2 inhibition in estrogen receptor positive breast cancer using in-silico and in vitro approches
Abstract Most of the breast cancers are estrogen receptor-positive recurring with a steady rate of up to 20 years dysregulating the normal cell cycle. Dinaciclib is still in clinical trials and considered as a research drug against such cancers targeting CDK2. The major goal of this study was to ide...
Main Authors: | Rida Sultan, Abrar Ahmed, Li Wei, Hamid Saeed, Muhammad Islam, Muhammad Ishaq |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-11-01
|
Series: | BMC Complementary Medicine and Therapies |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12906-023-04198-z |
Similar Items
-
A Comprehensive In Silico Exploration of Pharmacological Properties, Bioactivities, Molecular Docking, and Anticancer Potential of Vieloplain F from <i>Xylopia vielana</i> Targeting B-Raf Kinase
by: Syed Shams ul Hassan, et al.
Published: (2022-01-01) -
Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies
by: Faten Farouk, et al.
Published: (2023-12-01) -
Integration of Hybridization Strategies in Pyridine–Urea Scaffolds for Novel Anticancer Agents: Design, Synthesis, and Mechanistic Insights
by: Sreenivasulu Godesi, et al.
Published: (2023-06-01) -
Potent Bioactive Compounds From Seaweed Waste to Combat Cancer Through Bioinformatics Investigation
by: Kaushik Kumar Bharadwaj, et al.
Published: (2022-04-01) -
Anticancer potential of phytochemicals from Oroxylum indicum targeting Lactate Dehydrogenase A through bioinformatic approach
by: Sheikh Sunzid Ahmed, et al.
Published: (2023-01-01)